Steven Burke Keith's Insider Trades & SAST Disclosures
Steven Burke Keith's most recent trade in Akebia Therapeutics Inc. was a trade of 7,144 Common Stock done at an average price of $1.8 . Disclosure was reported to the exchange on March 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Steven Burke Keith.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Akebia Therapeutics Inc.
|
Steven Keith Burke | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.83 per share. | 03 Mar 2025 | 7,144 | 809,090 (0%) | 0% | 1.8 | 13,074 | Common Stock |
|
Akebia Therapeutics Inc.
|
Steven Keith Burke | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 292,300 | 292,300 | - | - | Stock Option (Right to buy) | |
|
Akebia Therapeutics Inc.
|
Steven Keith Burke | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 194,900 | 866,740 (0%) | 0% | 0 | Common Stock | |
|
Akebia Therapeutics Inc.
|
Steven Keith Burke | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.10 per share. | 31 Jan 2025 | 27,236 | 816,234 (0%) | 0% | 2.1 | 57,196 | Common Stock |
|
Akebia Therapeutics Inc.
|
Steven Keith Burke | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.10 per share. | 31 Jan 2025 | 23,270 | 843,470 (0%) | 0% | 2.1 | 48,867 | Common Stock |
|
Akebia Therapeutics Inc.
|
Steven Keith Burke | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.58 per share. | 29 Feb 2024 | 7,169 | 695,840 (0%) | 0% | 1.6 | 11,327 | Common Stock |
|
Akebia Therapeutics Inc.
|
Burke Keith Steven | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.52 per share. | 27 Feb 2024 | 8,367 | 703,009 (0%) | 0% | 1.5 | 12,718 | Common Stock |
|
Akebia Therapeutics Inc.
|
Steven Burke Keith | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 303,300 | 303,300 | - | - | Stock Option (Right to buy) | |
|
Akebia Therapeutics Inc.
|
Keith Burke Steven | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 202,200 | 735,687 (0%) | 0% | 0 | Common Stock | |
|
Akebia Therapeutics Inc.
|
Steven Burke Keith | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.68 per share. | 31 Jan 2024 | 24,311 | 711,376 (0%) | 0% | 1.7 | 40,842 | Common Stock |
|
Akebia Therapeutics Inc.
|
Steven Keith Burke | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.15 per share. | 25 Aug 2023 | 27,000 | 668,840 (0%) | 0% | 1.2 | 31,050 | Common Stock |
|
Akebia Therapeutics Inc.
|
Steven Keith Burke | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.07 per share. | 16 May 2023 | 63,567 | 530,487 (0%) | 0% | 1.1 | 67,890 | Common Stock |
|
Akebia Therapeutics Inc.
|
Steven Keith Burke | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.88 per share. | 01 Mar 2023 | 6,613 | 601,564 (0%) | 0% | 0.9 | 5,803 | Common Stock |
|
Akebia Therapeutics Inc.
|
Steven Keith Burke | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.88 per share. | 01 Mar 2023 | 6,400 | 595,164 (0%) | 0% | 0.9 | 5,616 | Common Stock |
|
Akebia Therapeutics Inc.
|
Steven Keith Burke | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.88 per share. | 01 Mar 2023 | 1,110 | 594,054 (0%) | 0% | 0.9 | 974 | Common Stock |
|
Akebia Therapeutics Inc.
|
Steven Keith Burke | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.81 per share. | 27 Feb 2023 | 7,539 | 608,177 (0%) | 0% | 0.8 | 6,131 | Common Stock |
|
Akebia Therapeutics Inc.
|
Steven Keith Burke | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 294,300 | 294,300 | - | - | Stock Option (Right to buy) | |
|
Akebia Therapeutics Inc.
|
Steven Keith Burke | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 196,200 | 615,716 (0%) | 0% | 0 | Common Stock | |
|
Akebia Therapeutics Inc.
|
Steven Keith Burke | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.36 per share. | 31 Aug 2022 | 1,147 | 418,016 (0%) | 0% | 0.4 | 416 | Common Stock |
|
Akebia Therapeutics Inc.
|
Steven Keith Burke | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 200,000 | 200,000 | - | - | Stock Option (Right to buy) | |
|
Akebia Therapeutics Inc.
|
Steven Keith Burke | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 200,000 | 417,663 (0%) | 0% | 0 | Common Stock | |
|
Akebia Therapeutics Inc.
|
Steven Keith Burke | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 225,000 | 225,000 | - | - | Employee Stock Option (Right to buy) | |
|
Akebia Therapeutics Inc.
|
Steven Keith Burke | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 60,000 | 223,819 (0%) | 0% | 0 | Common Stock | |
|
Akebia Therapeutics Inc.
|
Steven Keith Burke | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.15 per share. | 28 Feb 2022 | 7,400 | 163,819 (0%) | 0% | 2.2 | 15,946 | Common Stock |
|
Akebia Therapeutics Inc.
|
Steven Keith Burke | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.17 per share. | 28 Feb 2022 | 6,556 | 217,263 (0%) | 0% | 2.2 | 14,231 | Common Stock |
|
Akebia Therapeutics Inc.
|
Steven Keith Burke | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.17 per share. | 28 Feb 2022 | 1,100 | 217,663 (0%) | 0% | 2.2 | 2,388 | Common Stock |
|
Akebia Therapeutics Inc.
|
Steven Keith Burke | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.83 per share. | 31 Aug 2021 | 1,042 | 171,219 (0%) | 0% | 2.8 | 2,949 | Common Stock |
|
Akebia Therapeutics Inc.
|
Steven Keith Burke | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 3.40 per share. | 01 Apr 2021 | 1,081 | 170,761 (0%) | 0% | 3.4 | 3,675 | Common Stock |
|
Akebia Therapeutics Inc.
|
Steven Keith Burke | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2021 | 10,400 | 171,842 (0%) | 0% | 0 | Common Stock | |
|
Akebia Therapeutics Inc.
|
Steven Keith Burke | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 120,000 | 120,000 | - | - | Employee Stock Option (Right to buy) | |
|
Akebia Therapeutics Inc.
|
Steven Keith Burke | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 70,000 | 169,000 (0%) | 0% | 0 | Common Stock | |
|
Akebia Therapeutics Inc.
|
Steven Keith Burke | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 3.40 per share. | 26 Feb 2021 | 7,558 | 161,442 (0%) | 0% | 3.4 | 25,668 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges